- Med Travellers
- 0 Comments
Allogenic Stem Cell Therapy for Muscular Dystrophy in India
Muscular dystrophy (MD) refers to a family of genetic disorders that are inherited and are demarcated by the progressive weakness and degeneration of muscle. It is caused by mutations in the genes responsible for the muscle structure or function that eventually leads to muscle weakness. There are multiple types of muscular dystrophy, with Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) as the most prevalent and dangerous form. Other types include limb-girdle muscular dystrophy, myotonic dystrophy, and facioscapulohumeral muscular dystrophy (FSHD).ย
Currently, muscular dystrophy does not have a cure and treatment normally consists of symptomatic treatment that improves quality of life and slows disease progression. Stem cell therapy is growing as a potential game-changer for treatment of muscular dystrophy. A promising aspect of stem cell therapy is allogenic stem cell therapy, which is the general process of moving stem cells from a โhealthyโ person into the patientโs body. Such stem cells may have the potential to regenerate muscle, reduce inflammation, and restore function.
India, with its rapidly advancing medical infrastructure and relatively affordable healthcare, has become a popular destination for stem cell therapy. This article provides a comprehensive look at allogeneic stem cell therapy for muscular dystrophy in India, including its mechanisms, the types of stem cells used, the benefits, the risks, and the institutions offering these treatments.
Understanding Muscular Dystrophy
Muscular dystrophy refers to a group of genetic disorders that cause the progressive weakness and breakdown of muscle tissues. Each type of MD is caused by mutations in specific genes that provide instructions for producing muscle proteins. The lack or dysfunction of these proteins causes muscle cells to deteriorate and be replaced by scar tissue and fat, weakening the muscles.
Common Types of Muscular Dystrophy:
1.ย Duchenne Muscular Dystrophy (DMD):
This is the most severe and common form of MD; generally, boys are the ones affected. The cause of this disease is the dystrophin gene mutations, which result in the absence of dystrophin, a protein necessary for muscle stability. DMD is a quick muscle decay disease with symptoms emerging in early childhood. It doesnโt stop its journey very late; most of the time, it leads to the wheelchair age of about 12 years, and death in the early 20s due to respiratory or cardiac problems is the ultimate outcome.
2.ย Becker Muscular Dystrophy (BMD):
BMD is almost the same as DMD, with the difference of BMD being less severe. This disease is also the result of mutations in the dystrophin gene, but some dystrophin protein is produced that is partially functional. Symptoms usually start in adolescence or early adulthood, and the symptoms progress at a slower pace than in DMD.
3.ย Limb-Girdle Muscular Dystrophy (LGMD):
LGMD is a disease of the muscles around the shoulders and hips. Mutation of various genes causes this disease, which eventually results in the malfunction of different proteins that are involved in the muscle integrity. The development of LGMD is milder than that of DMD.
4.ย Myotonic Dystrophy:
Adult-Myotonic Dystrophy is the commonest of the MD adult types, and it is mainly characterized by muscle weakness, myotonia (delayed muscle relaxation), and other systemic changes such as heart problems and cataracts. This disease results from a mutation in the DMPK gene.
5.ย Facioscapulohumeral Muscular Dystrophy (FSHD):
FSHD is a disease in which the muscles of the face, shoulders, and upper arms are usually the ones to be affected. A genetic mutation is responsible for this condition, which leads to an unexpected turning-on of some genes, which facilitate the muscle degeneration.
Regardless of the fact that each of the muscular dystrophy types is distinguished by specific symptoms, they all have one thing in common, i.e., the progressive destruction of the skeletal muscles, which results in the reduction of mobility, independence, and, in the worst cases, even early death.